BridgeMD
Tests treatment safety and results for Osteoarthritis (OA)
Official title The Effectiveness of a Herbal Supplement in Osteoarthritis.
ClinicalTrials.gov ID: NCT07324746
What this study is testing
- What it's testing
- This study aims to evaluate the effectiveness and safety of a combined herbal supplement containing Boswellia serrata, Curcuma longa, and Vitis vinifera in adults with clinically diagnosed knee or hip osteoarthritis. The primary objective is to determine whether the supplement improves osteoarthritis-related symptoms.
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Aged ≥ 18
- Diagnosis of osteoarthritis in knee or hip
- Numerical Rating Scale (NRS) ≥ 4 during the most painful movement in the last 24 hours
- Lequesne's Functional Index (LFI) score ≥ 7
- Ambulant patient
You likely can't join if
- Pregnant and breastfeeding
- Autoimmune disease such as rheumatoid arthritis, gout, lupus
- Joint trauma, joint injury, joint infection, meniscus tear, complete loss of articular cartilage
- Expectation of surgery
- History of the viscous or corticosteroids injections into affected joints or oral corticosteroids within last 12 months
- Allergy to one of the intervention's ingredients or NSAIDs
See the full eligibility criteria
- Aged ≥ 18
- Diagnosis of osteoarthritis in knee or hip
- Numerical Rating Scale (NRS) ≥ 4 during the most painful movement in the last 24 hours
- Lequesne's Functional Index (LFI) score ≥ 7
- Ambulant patient
- Pregnant and breastfeeding
- Autoimmune disease such as rheumatoid arthritis, gout, lupus
- Joint trauma, joint injury, joint infection, meniscus tear, complete loss of articular cartilage
- Expectation of surgery
- History of the viscous or corticosteroids injections into affected joints or oral corticosteroids within last 12 months
- Allergy to one of the intervention's ingredients or NSAIDs
- Peptic ulceration and upper gastrointestinal haemorrhage
- High alcohol intake, inability to abstain from alcohol, substance abuse, history of addiction
- Tumor, cancer
- Abnormal renal or/and hepatic functions or altered blood chemistry
- Use of concomitant medication able to interfere with the interventions
The study team makes the final eligibility decision.
Where it's taking place
- London, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include London, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.